<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02538263</url>
  </required_header>
  <id_info>
    <org_study_id>BeijingCYH-TVV-58</org_study_id>
    <nct_id>NCT02538263</nct_id>
  </id_info>
  <brief_title>Volume-targeted Versus Pressure-limited Noninvasive Ventilation in Patients With Acute Hypercapnic Respiratory Failure</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <brief_summary>
    <textblock>
      Volume-targeted noninvasive ventilation (VT-NIV), a hybrid mode that targets a preseted tidal
      volume (VT) by automated adjustment of pressure support, could guarantee the delivered VT
      over pressure-limited noninvasive ventilation (PL-NIV) with fixed level pressure support.
      Whether VT-NIV is more effective in improving gas exchange in patients with acute hypercapnic
      respiratory failure (AHRF) as compared with PL-NIV remains unclear. Our aim was to verify
      whether in comparison with PL-NIV, use of VT-NIV was more effective in correcting
      hypercapnia, hence reducing the need for intubation and improving survival in patients with
      AHRF.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The decrease of arterial partial pressure of carbon dioxide (PaCO2) values from baseline to 6 hours after randomization</measure>
    <time_frame>6 hours after randomization</time_frame>
    <description>PaCO2 value at baseline minus PaCO2 value at 6 hours after randomization</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Acute Hypercapnic Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Volume-targeted noninvasive ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For Volume-targeted noninvasive ventilation, the target VT was set at 10 ml/kg of ideal body weight, with inspiratory positive airway pressure (IPAP) ranging from 10 cmH2O up to 25 cmH2O.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pressure-limited noninvasive ventilation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>For Pressure-limited noninvasive ventilation, IPAP was initially set at 10 cmH2O, and was adjusted by increments of 1-2 cmH2O according to patients' tolerance (up to 25 cmH2O) to obtain a VT of 8-10 ml/kg of ideal body weight and a respiratory rate (RR) less than 25 breaths/min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Volume-targeted noninvasive ventilation</intervention_name>
    <arm_group_label>Volume-targeted noninvasive ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute hypercapnic respiratory failure (AHRF)

          -  arterial pH &lt;7.35 and â‰¥7.25

          -  PaCO2 &gt;45 mmHg

        Exclusion Criteria:

          -  age &lt;18 years

          -  excessive amount of respiratory secretions or weak cough

          -  upper airway obstruction

          -  recent oral, facial or cranial trauma or surgery

          -  recent gastric or esophageal surgery

          -  severe metabolic acidosis; severe abdominal distension

          -  cardiac or respiratory arrest

          -  PaO2/FiO2 &lt;150 mmHg

          -  pneumothorax

          -  severe ventricular arrhythmia or myocardial ischemia

          -  severe hemodynamic instability despite fluid repletion and use of vasoactive agents

          -  active upper gastrointestinal bleeding

          -  lack of cooperation

          -  refusal to receive NIV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Beijing Institute of Respiratory Medicine, Department of respiratory and critical care medicine, Beijing Chao-Yang Hospital Jingxi Campus, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2015</study_first_submitted>
  <study_first_submitted_qc>August 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2015</study_first_posted>
  <last_update_submitted>August 29, 2015</last_update_submitted>
  <last_update_submitted_qc>August 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chao Yang Hospital</investigator_affiliation>
    <investigator_full_name>Zujin Luo</investigator_full_name>
    <investigator_title>Attending physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

